Introduction {#s0001}
============

Methylphenidate hydrochloride (MPH) is used in the treatment of attention deficit hyperactivity disorder (ADHD). Prescriptions for and usage of MPH products have increased sharply since the early 1990s with accompanying concerns about potential misuse.^[@CIT0001],[@CIT0002],[@CIT0003]^ While peer pressure and experimentation are important factors that contribute to substance use and misuse in young populations, students often experience strain to perform academically. Various strategies are followed to 'pull all-nighters' while studying for tests and exams, including the use of MPH to strengthen concentration and the ability to study for prolonged periods of time.^[@CIT0003],[@CIT0004],[@CIT0005],[@CIT0006]^ However, evidence is inconclusive whether MPH lives up to the perception of the substance enhancing mental alertness and cognitive performance in persons not clinically diagnosed with ADHD.^[@CIT0002],[@CIT0007]^

Self-reported MPH use in student populations ranges from 5% to 34%,^[@CIT0005],[@CIT0008],[@CIT0009],[@CIT0010]^ yet only 3% to 10% of MPH users have been diagnosed with ADHD.^[@CIT0003],[@CIT0010],[@CIT0011]^ Knowledge about the use of MPH as a study aid appears rife in universities, with up to 44% of students knowing a fellow student who uses MPH for academic reasons.^[@CIT0010]^ Characteristics of students who are more likely to use MPH include being white, male, having attended a private school and students who present higher rates of using substances^[@CIT0003],[@CIT0005],[@CIT0006],[@CIT0011]^ such as alcohol, tobacco (cigarettes), cannabis, cocaine, ecstasy and amphetamines.^[@CIT0006]^

Students use MPH mainly to strengthen concentration, cognition, interest, attention, alertness, energy, focus and memory, to reduce fatigue, to improve academic performance and for recreational purposes.^[@CIT0003],[@CIT0005],[@CIT0006],[@CIT0008],[@CIT0009],[@CIT0010],[@CIT0011]^ Very few students use MPH to socialise.^[@CIT0005],[@CIT0011]^ Instead, it appears that MPH is used primarily in times of high academic stress (i.e. test weeks and exams).^[@CIT0011]^ Procurement of MPH products is reportedly both easy and free from stigma.^[@CIT0003],[@CIT0008]^

Students mostly take MPH orally with a small proportion taking MPH intra-nasally.^[@CIT0003],[@CIT0010]^ Various side effects of MPH have been reported, including loss of appetite, difficulty sleeping, irritability and a depressed mood.^[@CIT0005]^ Nonetheless, students who use MPH show little concern about using or misusing the substance^[@CIT0003]^ despite health-threatening consequences if usage is not professionally monitored.^[@CIT0002]^

Aim and methods {#s0002}
===============

The aim of the study was, firstly, to determine the use and dynamics associated with the use of MPH among undergraduate students attending a South African university and, secondly, to determine whether MPH users are more likely to use other substances compared to non-MPH users. Quantitative methods were employed to obtain data from 818 undergraduate students. A group-administered survey design was followed since this strategy ensures anonymity, which was imperative given that students were asked to respond to questions of (illegal) substance use. The survey took place over two days during the undergraduate classes of a discipline that attracts a large number of students annually. Questionnaires and letters of informed consent were distributed in class followed by an explanation of the purpose and procedures of the survey. Students were requested to complete the questionnaire in writing and to not discuss the questions or their answers with fellow students. Students were instructed to fold the completed one-page questionnaires twice so that others could not read their responses during collection.

The questionnaire designed by White et al.^[@CIT0003]^ was adapted to reflect local terms (for example 'first year' instead of 'freshman') and to reduce the 10 open-ended questions to only one. In addition, questions were added about the frequency of students' use of alcohol, tobacco (cigarettes), cannabis, hard drugs (e.g. cocaine) and prescription medication. MPH use in this survey refers to 'have ever used' MPH products with follow-up questions regarding frequency and method of use, sourcing, side effects and openness of use. The questionnaire was piloted with 50 students from other faculties, after which minor alterations were made. Data were captured manually in Microsoft Excel and exported to the Statistical Package for the Social Sciences (version 22).^[@CIT0012]^ Inspection of the histograms with normality curves and tests of normality (Kolmogorov-Smirnov *Z*) revealed that the data were not normally distributed. The outcome thus necessitated the use of non-parametric tests to determine significant differences, in particular Pearson's chi-square and the Mann-Whitney *U* test for which effect sizes (*r*) were calculated.^[@CIT0013]^

 {#s20003}

### Ethical considerations {#s30004}

The survey adhered to the standard ethical considerations of anonymity, confidentiality and no harm. Respondents were provided with an information sheet which described the purpose and methods of the study, as well as the particulars of organisations that they could contact should they have concerns about their use of substances. Ethical clearance for the survey was obtained from the faculty's ethics committee and the registrar of the university.

Results {#s0005}
=======

Characteristics of the sample and methylphenidate use {#s20006}
-----------------------------------------------------

The mean age of respondents was 20.38 years (SD = 2.19 years). Female respondents constituted the bulk of the sample and the majority of respondents came from middle-income backgrounds ([Table 1](#T0001){ref-type="table"}). Male and white respondents, as well as those from high-income backgrounds, appear more prone to using MPH. Population group (*r* = --0.25) showed a stronger effect size for MPH use than gender (*r* = --0.07) and economic background (*r* = --0.08).

###### 

Background characteristics of respondents and methylphenidate use.

  Variable                      Total   MPH used   MPH not used   *p*    *r*                     
  ----------------------------- ------- ---------- -------------- ------ ----- ------ ---------- --------
  **Gender**                                                                                     
  Male                          185     22.7       42             22.7   143   77.3   \< 0.001   --0.07
  Female                        630     77.3       99             15.7   531   84.3   \-         \-
  **Population group**                                                                           
  Black                         244     29.8       9              3.7    235   96.3   \< 0.001   --0.25
  Mixed-race                    48      5.9        7              14.6   41    85.4   \-         \-
  Indian/Asian                  28      3.4        1              3.6    27    96.4   \-         \-
  White                         499     60.9       124            24.8   375   75.2   \-         \-
  **Economic background**                                                                        
  Low                           72      8.8        6              8.3    66    91.7   0.019      --0.08
  Middle                        616     75.6       107            17.4   509   82.6   \-         \-
  High                          127     15.6       28             22.0   99    78.0   \-         \-
  **Type of school attended**                                                                    
  Public                        567     69.7       90             15.9   447   84.1   0.098      \-
  Private                       247     30.3       51             20.6   196   79.4   \-         \-

*Source*: Author's own work.

### Dynamics of methylphenidate use {#s30007}

Nearly half of all respondents (*n* = 382; 46.8%) know of a fellow student who used MPH. One in six respondents (*n* = 141; 17.2%) has used MPH in the past, although only 2.9% (*n* = 23) of all respondents has been diagnosed with ADHD. Nearly a third (*n* = 33; 31.7%) of MPH users do not have a prescription for the stimulant, with 27.3% (*n* = 30) of users obtaining MPH products from a friend (at an average cost of R35.00 per tablet).

The greater proportion of MPH users started using the substance at university (*n* = 71; 68.3%) and the remainder commenced MPH use at school (*n* = 33; 31.7%). The majority of respondents (*n* = 65; 69.1%) reported using MPH only during tests and exams, with 17.0% (*n* = 16) using MPH daily. A small proportion of respondents use MPH once or twice per week (n = 3; 3.3%), three to four times per week (*n* = 5; 5.4%) and once or twice per month (*n* = 5; 5.4%). The larger part of MPH users indicated that it is very easy (*n* = 47; 41.2%), somewhat easy (*n* = 27; 23.7%) and neither easy nor difficult (*n* = 25; 21.9%) to obtain MPH products. Nine users (7.9%) noted it somewhat difficult and six (5.3%) stated that it is very difficult to obtain MPH products. More than half of users (*n* = 62; 58.5%) indicated that they are open about using MPH, 35.8% (*n* = 38) stated that only those close to them know and six (5.6%) noted that they keep it a secret.

Only one respondent (0.9%) takes MPH intra-nasally with the vast majority taking the stimulant orally (*n* = 106; 99.1%). The reasons for using MPH were to enhance concentration (41.7%), to improve study habits (26.4%), to reduce hyperactivity (10.2%), to achieve higher marks (19.1%) and for socialising (2.1%). MPH users experienced a variety of side effects of which the five most often cited were insomnia (*n* = 13; 17.3%), moodiness (*n* = 11; 14.7%), loss of appetite (*n* = 9; 12.0%), dry mouth (*n* = 6; 8.0%) and anxiety (*n* = 5; 6.7%).

### Methylphenidate and use of other substances {#s30008}

Although a significant association featured for the co-use of MPH and other substances, tobacco (*r* = 0.24) and cannabis (*r* = 0.21) presented the strongest effect sizes of poly-substance use ([Table 2](#T0002){ref-type="table"}).

###### 

Methylphenidate and use of other substances.

  Variable                    MPH used   MPH not used   *p*   *r*               
  --------------------------- ---------- -------------- ----- ------ ---------- ------
  Alcohol                     120        88.8           526   79.1   0.008      0.09
  Tobacco                     67         52.3           147   22.8   \< 0.001   0.24
  Cannabis                    57         44.5           127   19.7   \< 0.001   0.21
  Hard drugs (e.g. cocaine)   7          5.7            5     0.8    \< 0.001   0.14
  Prescription medication     114        85.1           455   70.0   \< 0.001   0.12

*Source*: Author's own work.

[Table 3](#T0003){ref-type="table"} cross-tabulates the results of MPH users and non-users with the self-reported frequency of using other substances. MPH users surpassed non-MPH users in the use of other substances in the 'often' and 'sometimes' categories.

###### 

Methylphenidate use and frequency of use of other substances.

  Variable         Alcohol    Tobacco    Cannabis   Hard drugs (e.g. cocaine)   Prescription medication                             
  ---------------- ---------- ---------- ---------- --------------------------- ------------------------- ------ ----- ------ ----- ------
  **Often:**                                                                                                                        
  Used             43         31.9       33         25.8                        16                        12.5   1     0.8    35    26.1
  Not used         105        15.8       55         8.5                         13                        2.0    0     0.0    103   15.8
  **Sometimes:**                                                                                                                    
  Used             49         36.3       14         10.9                        11                        8.6    3     2.4    36    26.9
  Not used         219        32.9       35         5.4                         24                        3.7    1     0.2    125   19.2
  **Seldom:**                                                                                                                       
  Used             28         20.7       20         15.6                        30                        23.4   3     2.4    43    32.1
  Not used         202        30.4       57         8.8                         87                        13.5   4     0.6    227   34.9
  **Never:**                                                                                                                        
  Used             15         11.1       61         47.7                        71                        55.5   116   94.3   20    14.9
  Not used         139        20.9       499        77.2                        519                       80.7   633   98.2   195   30.0
  *p*              \< 0.001   \< 0.001   \< 0.001   \< 0.001                    \< 0.001                                            
  *r*              --0.16     --0.25     --0.23     --0.14                      --0.15                                              

*Source*: Author's own work.

Discussion {#s0009}
==========

Results from the present survey are similar to findings from abroad regarding the self-reported use of MPH among students (17.2%)^[@CIT0003],[@CIT0010]^ and the finding that a small proportion of MPH users has been diagnosed with ADHD (2.7%).^[@CIT0003],[@CIT0010],[@CIT0011]^ In the same way, the reasons why students use MPH (mostly to enhance academic performance) and the side effects they experience (notably sleeping disturbances, loss of appetite and moodiness) correspond with existing evidence.^[@CIT0003],[@CIT0005],[@CIT0006],[@CIT0008],[@CIT0009],[@CIT0010],[@CIT0011]^ Furthermore, the results show that MPH users are more prone to using other substances,^[@CIT0006]^ although MPH poly-use with tobacco and cannabis appears more pronounced. The study further supports findings that white students and those from higher-income backgrounds are associated with higher levels of MPH use,^[@CIT0005],[@CIT0006],[@CIT0011]^ possibly due to this profile in South Africa generally having better access to private medical aid and accompanying specialised health care.

Similar to the available evidence, students do not appear to use MPH for socialising purposes but primarily during periods of academic stress.^[@CIT0005],[@CIT0011]^ Nearly a third of users did not have a prescription for MPH, thus indicating that they obtain products illegally. These findings raise concerns that students with MPH prescriptions may stockpile their medication over time in order to share it with or to sell it to fellow students. As elsewhere, the results confirm that local MPH users are relatively open about using the substance and that it is relatively easy to obtain MPH products,^[@CIT0003],[@CIT0008]^ whether via licit or illicit channels. With nearly half of respondents in the present survey knowing of a fellow student who uses MPH and the majority of users having commenced MPH use at university, it is clear that some form of awareness exists and may be perpetuated on campus about the perceived benefits of MPH as a study aid.

Recommendations {#s0010}
===============

University management and student support services should create awareness among parents and students about the health risks associated with the misuse of MPH products. Steps should be taken to prevent students with MPH prescriptions from sharing their medication with fellow students.^[@CIT0003]^ Medical practitioners and pharmacists should take note of the misuse of MPH among students and carefully follow relevant diagnosis and monitoring protocols in the prescription and dispensing of MPH products, even more so in light of irregular use, sharing and selling of medication and poly-substance use.

Limitations and future research {#s0011}
===============================

The study relied on non-probability sampling procedures and, despite the large number of respondents, generalisation to other settings and populations should be done with caution. Matters of representation are further confounded by not all students attending class, attrition and the bulk of respondents stemming from one specific faculty. Regardless of assurances of anonymity, the study depended on measures of self-report, which is known for under-reporting in matters such as substance use.

Future research, with random and stratified sampling procedures, should focus on MPH use across academic faculties and institutions of higher education. The views of stakeholders, in particular medical practitioners and pharmacists, should be determined regarding the use of MPH among student populations. In addition, a more definite profile of the users of MPH products should be developed in order to identify risk populations and appropriate interventions.
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